QY Research > レポート一覧 > メディカルケア > 糞便移植治療世界市場の発展状況と動向 2024-2030

糞便移植治療世界市場の発展状況と動向 2024-2030

英文タイトル: Global Fecal Transplant Treatment Market Insights, Forecast to 2030

糞便移植治療世界市場の発展状況と動向 2024-2030
  • レポートID:315934
  • 発表時期:2024-04-27
  • 訪問回数:537
  • ページ数:112
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:134
  • レポートカテゴリ: メディカルケア

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=147.60円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=147.60円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は、糞便移植治療の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に糞便移植治療市場を分類しています。

本レポートでは世界の糞便移植治療市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は:Enterome Bioscience、Rebiotix、Ritter Pharmaceuticals、Finch Therapeutics、Crestovo、MaaT Pharma、Seres Therapeutics、Second Genome、OpenBiome、MicroBiome Therapeutics

レポートは糞便移植治療の主要生産者を調査し、主要地域や国の消費状況も提供します。糞便移植治療の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント:
Fecal Transfusion
Fecal Bacteria Therapy
Fecal Enema
Fecal Transplant
Others

用途別の市場セグメント:
Parkinson's Diseaseo
Obesity
Autism
Clostridium Difficile Infection
Diabetes Mellitus
Others

レポートの詳細内容
本レポートは、世界の糞便移植治療市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて糞便移植治療市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別(地域レベル、国レベル)の糞便移植治療生産量、成長率、市場シェアを調査している。

二. 消費面では、糞便移植治療の売上高を地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの糞便移植治療売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の糞便移植治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本糞便移植治療のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

1章:糞便移植治療のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー(タイプ別およびアプリケーション別など)を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。(20202031
2章: 糞便移植治療の世界と主要生産者(地域/国)の生産/アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。(20202031
3章:世界、地域、国レベルにおける糞便移植治療の売上(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。(20202031
4糞便移植治療メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。(20202025
5章:糞便移植治療の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20202031
6章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。(20202031
7章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。(20202031
8章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。(20202031
9章:中国:タイプ別、アプリケーション別、セグメント別の売上高、収益。(20202031
10章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。(20202031
11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。(20202031
12章:糞便移植治療の主要メーカーの概要を提供し、製品の説明と仕様、糞便移植治療の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。(20202025
13章:産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
14章:糞便移植治療の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
15章:レポートの要点と結論。

biaoTi

概要

Market Analysis and Insights: Global Fecal Transplant Treatment Market
The global Fecal Transplant Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Fecal Transplant Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Fecal Transplant Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Fecal Transplant Treatment is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Fecal Transplant Treatment include Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics, Crestovo, MaaT Pharma, Seres Therapeutics, Second Genome and OpenBiome, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Fecal Transplant Treatment is widely used in various fields, such as Parkinson's Diseaseo, Obesity, Autism and Clostridium Difficile Infection, etc. Parkinson's Diseaseo provides greatest supports to the Fecal Transplant Treatment industry development. In 2023, global % revenue of Fecal Transplant Treatment went into Parkinson's Diseaseo filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Fecal Transplant Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Fecal Transplant Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Fecal Transplant Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fecal Transplant Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Fecal Transplant Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Fecal Transplant Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics, Crestovo, MaaT Pharma, Seres Therapeutics, Second Genome and OpenBiome, etc.

Market Segmentation
By Company
    Enterome Bioscience
    Rebiotix
    Ritter Pharmaceuticals
    Finch Therapeutics
    Crestovo
    MaaT Pharma
    Seres Therapeutics
    Second Genome
    OpenBiome
    MicroBiome Therapeutics

Segment by Type
    Fecal Transfusion
    Fecal Bacteria Therapy
    Fecal Enema
    Fecal Transplant
    Others

Segment by Application
    Parkinson's Diseaseo
    Obesity
    Autism
    Clostridium Difficile Infection
    Diabetes Mellitus
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Fecal Transplant Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fecal Transplant Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fecal Transplant Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fecal Transplant Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Fecal Transfusion
1.2.3 Fecal Bacteria Therapy
1.2.4 Fecal Enema
1.2.5 Fecal Transplant
1.2.6 Others
1.3 Market by Application
1.3.1 Global Fecal Transplant Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Parkinson's Diseaseo
1.3.3 Obesity
1.3.4 Autism
1.3.5 Clostridium Difficile Infection
1.3.6 Diabetes Mellitus
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Fecal Transplant Treatment Market Perspective (2019-2030)
2.2 Global Fecal Transplant Treatment Growth Trends by Region
2.2.1 Fecal Transplant Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fecal Transplant Treatment Historic Market Size by Region (2019-2024)
2.2.3 Fecal Transplant Treatment Forecasted Market Size by Region (2025-2030)
2.3 Fecal Transplant Treatment Market Dynamics
2.3.1 Fecal Transplant Treatment Industry Trends
2.3.2 Fecal Transplant Treatment Market Drivers
2.3.3 Fecal Transplant Treatment Market Challenges
2.3.4 Fecal Transplant Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Fecal Transplant Treatment by Players
3.1.1 Global Fecal Transplant Treatment Revenue by Players (2019-2024)
3.1.2 Global Fecal Transplant Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Fecal Transplant Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Fecal Transplant Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Fecal Transplant Treatment Market Concentration Ratio
3.4.1 Global Fecal Transplant Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fecal Transplant Treatment Revenue in 2023
3.5 Global Key Players of Fecal Transplant Treatment Head office and Area Served
3.6 Global Key Players of Fecal Transplant Treatment, Product and Application
3.7 Global Key Players of Fecal Transplant Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Fecal Transplant Treatment Breakdown Data by Type
4.1 Global Fecal Transplant Treatment Historic Market Size by Type (2019-2024)
4.2 Global Fecal Transplant Treatment Forecasted Market Size by Type (2025-2030)

5 Fecal Transplant Treatment Breakdown Data by Application
5.1 Global Fecal Transplant Treatment Historic Market Size by Application (2019-2024)
5.2 Global Fecal Transplant Treatment Forecasted Market Size by Application (2025-2030)

6 North America
6.1 North America Fecal Transplant Treatment Market Size (2019-2030)
6.2 North America Fecal Transplant Treatment Market Size by Type
6.2.1 North America Fecal Transplant Treatment Market Size by Type (2019-2024)
6.2.2 North America Fecal Transplant Treatment Market Size by Type (2025-2030)
6.2.3 North America Fecal Transplant Treatment Market Share by Type (2019-2030)
6.3 North America Fecal Transplant Treatment Market Size by Application
6.3.1 North America Fecal Transplant Treatment Market Size by Application (2019-2024)
6.3.2 North America Fecal Transplant Treatment Market Size by Application (2025-2030)
6.3.3 North America Fecal Transplant Treatment Market Share by Application (2019-2030)
6.4 North America Fecal Transplant Treatment Market Size by Country
6.4.1 North America Fecal Transplant Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Fecal Transplant Treatment Market Size by Country (2019-2024)
6.4.3 North America Fecal Transplant Treatment Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada

7 Europe
7.1 Europe Fecal Transplant Treatment Market Size (2019-2030)
7.2 Europe Fecal Transplant Treatment Market Size by Type
7.2.1 Europe Fecal Transplant Treatment Market Size by Type (2019-2024)
7.2.2 Europe Fecal Transplant Treatment Market Size by Type (2025-2030)
7.2.3 Europe Fecal Transplant Treatment Market Share by Type (2019-2030)
7.3 Europe Fecal Transplant Treatment Market Size by Application
7.3.1 Europe Fecal Transplant Treatment Market Size by Application (2019-2024)
7.3.2 Europe Fecal Transplant Treatment Market Size by Application (2025-2030)
7.3.3 Europe Fecal Transplant Treatment Market Share by Application (2019-2030)
7.4 Europe Fecal Transplant Treatment Market Size by Country
7.4.1 Europe Fecal Transplant Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Fecal Transplant Treatment Market Size by Country (2019-2024)
7.4.3 Europe Fecal Transplant Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China Fecal Transplant Treatment Market Size (2019-2030)
8.2 China Fecal Transplant Treatment Market Size by Type
8.2.1 China Fecal Transplant Treatment Market Size by Type (2019-2024)
8.2.2 China Fecal Transplant Treatment Market Size by Type (2025-2030)
8.2.3 China Fecal Transplant Treatment Market Share by Type (2019-2030)
8.3 China Fecal Transplant Treatment Market Size by Application
8.3.1 China Fecal Transplant Treatment Market Size by Application (2019-2024)
8.3.2 China Fecal Transplant Treatment Market Size by Application (2025-2030)
8.3.3 China Fecal Transplant Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Fecal Transplant Treatment Market Size (2019-2030)
9.2 Asia Fecal Transplant Treatment Market Size by Type
9.2.1 Asia Fecal Transplant Treatment Market Size by Type (2019-2024)
9.2.2 Asia Fecal Transplant Treatment Market Size by Type (2025-2030)
9.2.3 Asia Fecal Transplant Treatment Market Share by Type (2019-2030)
9.3 Asia Fecal Transplant Treatment Market Size by Application
9.3.1 Asia Fecal Transplant Treatment Market Size by Application (2019-2024)
9.3.2 Asia Fecal Transplant Treatment Market Size by Application (2025-2030)
9.3.3 Asia Fecal Transplant Treatment Market Share by Application (2019-2030)
9.4 Asia Fecal Transplant Treatment Market Size by Region
9.4.1 Asia Fecal Transplant Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Fecal Transplant Treatment Market Size by Region (2019-2024)
9.4.3 Asia Fecal Transplant Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries

11 Key Players Profiles
11.1 Enterome Bioscience
11.1.1 Enterome Bioscience Company Details
11.1.2 Enterome Bioscience Business Overview
11.1.3 Enterome Bioscience Fecal Transplant Treatment Introduction
11.1.4 Enterome Bioscience Revenue in Fecal Transplant Treatment Business (2019-2024)
11.1.5 Enterome Bioscience Recent Developments
11.2 Rebiotix
11.2.1 Rebiotix Company Details
11.2.2 Rebiotix Business Overview
11.2.3 Rebiotix Fecal Transplant Treatment Introduction
11.2.4 Rebiotix Revenue in Fecal Transplant Treatment Business (2019-2024)
11.2.5 Rebiotix Recent Developments
11.3 Ritter Pharmaceuticals
11.3.1 Ritter Pharmaceuticals Company Details
11.3.2 Ritter Pharmaceuticals Business Overview
11.3.3 Ritter Pharmaceuticals Fecal Transplant Treatment Introduction
11.3.4 Ritter Pharmaceuticals Revenue in Fecal Transplant Treatment Business (2019-2024)
11.3.5 Ritter Pharmaceuticals Recent Developments
11.4 Finch Therapeutics
11.4.1 Finch Therapeutics Company Details
11.4.2 Finch Therapeutics Business Overview
11.4.3 Finch Therapeutics Fecal Transplant Treatment Introduction
11.4.4 Finch Therapeutics Revenue in Fecal Transplant Treatment Business (2019-2024)
11.4.5 Finch Therapeutics Recent Developments
11.5 Crestovo
11.5.1 Crestovo Company Details
11.5.2 Crestovo Business Overview
11.5.3 Crestovo Fecal Transplant Treatment Introduction
11.5.4 Crestovo Revenue in Fecal Transplant Treatment Business (2019-2024)
11.5.5 Crestovo Recent Developments
11.6 MaaT Pharma
11.6.1 MaaT Pharma Company Details
11.6.2 MaaT Pharma Business Overview
11.6.3 MaaT Pharma Fecal Transplant Treatment Introduction
11.6.4 MaaT Pharma Revenue in Fecal Transplant Treatment Business (2019-2024)
11.6.5 MaaT Pharma Recent Developments
11.7 Seres Therapeutics
11.7.1 Seres Therapeutics Company Details
11.7.2 Seres Therapeutics Business Overview
11.7.3 Seres Therapeutics Fecal Transplant Treatment Introduction
11.7.4 Seres Therapeutics Revenue in Fecal Transplant Treatment Business (2019-2024)
11.7.5 Seres Therapeutics Recent Developments
11.8 Second Genome
11.8.1 Second Genome Company Details
11.8.2 Second Genome Business Overview
11.8.3 Second Genome Fecal Transplant Treatment Introduction
11.8.4 Second Genome Revenue in Fecal Transplant Treatment Business (2019-2024)
11.8.5 Second Genome Recent Developments
11.9 OpenBiome
11.9.1 OpenBiome Company Details
11.9.2 OpenBiome Business Overview
11.9.3 OpenBiome Fecal Transplant Treatment Introduction
11.9.4 OpenBiome Revenue in Fecal Transplant Treatment Business (2019-2024)
11.9.5 OpenBiome Recent Developments
11.10 MicroBiome Therapeutics
11.10.1 MicroBiome Therapeutics Company Details
11.10.2 MicroBiome Therapeutics Business Overview
11.10.3 MicroBiome Therapeutics Fecal Transplant Treatment Introduction
11.10.4 MicroBiome Therapeutics Revenue in Fecal Transplant Treatment Business (2019-2024)
11.10.5 MicroBiome Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

biaoTi

表と図のリスト

List of Tables
    Table 1. Global Fecal Transplant Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Fecal Transfusion
    Table 3. Key Players of Fecal Bacteria Therapy
    Table 4. Key Players of Fecal Enema
    Table 5. Key Players of Fecal Transplant
    Table 6. Key Players of Others
    Table 7. Global Fecal Transplant Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Fecal Transplant Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Fecal Transplant Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Fecal Transplant Treatment Market Share by Region (2019-2024)
    Table 11. Global Fecal Transplant Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Fecal Transplant Treatment Market Share by Region (2025-2030)
    Table 13. Fecal Transplant Treatment Market Trends
    Table 14. Fecal Transplant Treatment Market Drivers
    Table 15. Fecal Transplant Treatment Market Challenges
    Table 16. Fecal Transplant Treatment Market Restraints
    Table 17. Global Fecal Transplant Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Fecal Transplant Treatment Revenue Share by Players (2019-2024)
    Table 19. Global Top Fecal Transplant Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fecal Transplant Treatment as of 2023)
    Table 20. Global Fecal Transplant Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Fecal Transplant Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Fecal Transplant Treatment, Headquarters and Area Served
    Table 23. Global Key Players of Fecal Transplant Treatment, Product and Application
    Table 24. Global Key Players of Fecal Transplant Treatment, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Fecal Transplant Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Fecal Transplant Treatment Revenue Market Share by Type (2019-2024)
    Table 28. Global Fecal Transplant Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Fecal Transplant Treatment Revenue Market Share by Type (2025-2030)
    Table 30. Global Fecal Transplant Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Fecal Transplant Treatment Revenue Share by Application (2019-2024)
    Table 32. Global Fecal Transplant Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Fecal Transplant Treatment Revenue Share by Application (2025-2030)
    Table 34. North America Fecal Transplant Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Fecal Transplant Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Fecal Transplant Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Fecal Transplant Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Fecal Transplant Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Fecal Transplant Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Fecal Transplant Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Fecal Transplant Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Fecal Transplant Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Fecal Transplant Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Fecal Transplant Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Fecal Transplant Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Fecal Transplant Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Fecal Transplant Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Fecal Transplant Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Fecal Transplant Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Fecal Transplant Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Fecal Transplant Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Fecal Transplant Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Fecal Transplant Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Fecal Transplant Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Fecal Transplant Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Fecal Transplant Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Fecal Transplant Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Fecal Transplant Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Fecal Transplant Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Enterome Bioscience Company Details
    Table 67. Enterome Bioscience Business Overview
    Table 68. Enterome Bioscience Fecal Transplant Treatment Product
    Table 69. Enterome Bioscience Revenue in Fecal Transplant Treatment Business (2019-2024) & (US$ Million)
    Table 70. Enterome Bioscience Recent Developments
    Table 71. Rebiotix Company Details
    Table 72. Rebiotix Business Overview
    Table 73. Rebiotix Fecal Transplant Treatment Product
    Table 74. Rebiotix Revenue in Fecal Transplant Treatment Business (2019-2024) & (US$ Million)
    Table 75. Rebiotix Recent Developments
    Table 76. Ritter Pharmaceuticals Company Details
    Table 77. Ritter Pharmaceuticals Business Overview
    Table 78. Ritter Pharmaceuticals Fecal Transplant Treatment Product
    Table 79. Ritter Pharmaceuticals Revenue in Fecal Transplant Treatment Business (2019-2024) & (US$ Million)
    Table 80. Ritter Pharmaceuticals Recent Developments
    Table 81. Finch Therapeutics Company Details
    Table 82. Finch Therapeutics Business Overview
    Table 83. Finch Therapeutics Fecal Transplant Treatment Product
    Table 84. Finch Therapeutics Revenue in Fecal Transplant Treatment Business (2019-2024) & (US$ Million)
    Table 85. Finch Therapeutics Recent Developments
    Table 86. Crestovo Company Details
    Table 87. Crestovo Business Overview
    Table 88. Crestovo Fecal Transplant Treatment Product
    Table 89. Crestovo Revenue in Fecal Transplant Treatment Business (2019-2024) & (US$ Million)
    Table 90. Crestovo Recent Developments
    Table 91. MaaT Pharma Company Details
    Table 92. MaaT Pharma Business Overview
    Table 93. MaaT Pharma Fecal Transplant Treatment Product
    Table 94. MaaT Pharma Revenue in Fecal Transplant Treatment Business (2019-2024) & (US$ Million)
    Table 95. MaaT Pharma Recent Developments
    Table 96. Seres Therapeutics Company Details
    Table 97. Seres Therapeutics Business Overview
    Table 98. Seres Therapeutics Fecal Transplant Treatment Product
    Table 99. Seres Therapeutics Revenue in Fecal Transplant Treatment Business (2019-2024) & (US$ Million)
    Table 100. Seres Therapeutics Recent Developments
    Table 101. Second Genome Company Details
    Table 102. Second Genome Business Overview
    Table 103. Second Genome Fecal Transplant Treatment Product
    Table 104. Second Genome Revenue in Fecal Transplant Treatment Business (2019-2024) & (US$ Million)
    Table 105. Second Genome Recent Developments
    Table 106. OpenBiome Company Details
    Table 107. OpenBiome Business Overview
    Table 108. OpenBiome Fecal Transplant Treatment Product
    Table 109. OpenBiome Revenue in Fecal Transplant Treatment Business (2019-2024) & (US$ Million)
    Table 110. OpenBiome Recent Developments
    Table 111. MicroBiome Therapeutics Company Details
    Table 112. MicroBiome Therapeutics Business Overview
    Table 113. MicroBiome Therapeutics Fecal Transplant Treatment Product
    Table 114. MicroBiome Therapeutics Revenue in Fecal Transplant Treatment Business (2019-2024) & (US$ Million)
    Table 115. MicroBiome Therapeutics Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Fecal Transplant Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Fecal Transplant Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Fecal Transfusion Features
    Figure 4. Fecal Bacteria Therapy Features
    Figure 5. Fecal Enema Features
    Figure 6. Fecal Transplant Features
    Figure 7. Others Features
    Figure 8. Global Fecal Transplant Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Fecal Transplant Treatment Market Share by Application: 2023 VS 2030
    Figure 10. Parkinson's Diseaseo Case Studies
    Figure 11. Obesity Case Studies
    Figure 12. Autism Case Studies
    Figure 13. Clostridium Difficile Infection Case Studies
    Figure 14. Diabetes Mellitus Case Studies
    Figure 15. Others Case Studies
    Figure 16. Fecal Transplant Treatment Report Years Considered
    Figure 17. Global Fecal Transplant Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 18. Global Fecal Transplant Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Fecal Transplant Treatment Market Share by Region: 2023 VS 2030
    Figure 20. Global Fecal Transplant Treatment Market Share by Players in 2023
    Figure 21. Global Top Fecal Transplant Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fecal Transplant Treatment as of 2023)
    Figure 22. The Top 10 and 5 Players Market Share by Fecal Transplant Treatment Revenue in 2023
    Figure 23. North America Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. North America Fecal Transplant Treatment Market Share by Type (2019-2030)
    Figure 25. North America Fecal Transplant Treatment Market Share by Application (2019-2030)
    Figure 26. North America Fecal Transplant Treatment Market Share by Country (2019-2030)
    Figure 27. United States Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Canada Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe Fecal Transplant Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 30. Europe Fecal Transplant Treatment Market Share by Type (2019-2030)
    Figure 31. Europe Fecal Transplant Treatment Market Share by Application (2019-2030)
    Figure 32. Europe Fecal Transplant Treatment Market Share by Country (2019-2030)
    Figure 33. Germany Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. France Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. U.K. Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Italy Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Russia Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Nordic Countries Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. China Fecal Transplant Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. China Fecal Transplant Treatment Market Share by Type (2019-2030)
    Figure 41. China Fecal Transplant Treatment Market Share by Application (2019-2030)
    Figure 42. Asia Fecal Transplant Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 43. Asia Fecal Transplant Treatment Market Share by Type (2019-2030)
    Figure 44. Asia Fecal Transplant Treatment Market Share by Application (2019-2030)
    Figure 45. Asia Fecal Transplant Treatment Market Share by Region (2019-2030)
    Figure 46. Japan Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. South Korea Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. China Taiwan Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. India Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Australia Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Share by Type (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Share by Application (2019-2030)
    Figure 55. Middle East, Africa, and Latin America Fecal Transplant Treatment Market Share by Country (2019-2030)
    Figure 56. Brazil Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Mexico Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Turkey Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Saudi Arabia Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Israel Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. GCC Countries Fecal Transplant Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Enterome Bioscience Revenue Growth Rate in Fecal Transplant Treatment Business (2019-2024)
    Figure 63. Rebiotix Revenue Growth Rate in Fecal Transplant Treatment Business (2019-2024)
    Figure 64. Ritter Pharmaceuticals Revenue Growth Rate in Fecal Transplant Treatment Business (2019-2024)
    Figure 65. Finch Therapeutics Revenue Growth Rate in Fecal Transplant Treatment Business (2019-2024)
    Figure 66. Crestovo Revenue Growth Rate in Fecal Transplant Treatment Business (2019-2024)
    Figure 67. MaaT Pharma Revenue Growth Rate in Fecal Transplant Treatment Business (2019-2024)
    Figure 68. Seres Therapeutics Revenue Growth Rate in Fecal Transplant Treatment Business (2019-2024)
    Figure 69. Second Genome Revenue Growth Rate in Fecal Transplant Treatment Business (2019-2024)
    Figure 70. OpenBiome Revenue Growth Rate in Fecal Transplant Treatment Business (2019-2024)
    Figure 71. MicroBiome Therapeutics Revenue Growth Rate in Fecal Transplant Treatment Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)